Sign Up | Log In | What is SocialPicks?

Applera Corp. Celera Group (CRA) Trade Now » Rate CRA - Discuss CRA - Add to Watch List

Sector: Services > Industry: Business Services

This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks

This Quarter's Sentiment:

All:

100.0%

Top:

100.0%

Rate CRA:

Home

Analysis & Videos

Quotes

Bull or Bear

Discuss

CRA Analysis & Videos »

... View All >

CRA: Bull or Bear?

Applera Corp. Celera Group CRA

62%

Celera Corporation delivers personalized disease management through a combination of products and services. It operates in three segments: Lab Services, Products, and Corporate. The Lab Services segment offers clinical laboratory tests and disease management services for healthcare providers to enhance cardiovascular disease treatment regimens for patients. It offers clinical laboratory testing services that characterize and monitor cardiovascular disease risk, and personalized treatment and ongoing therapeutic compliance education services. The principal tests offered by this segment inclu...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 08/05/09

7 comments

New Preventive Medicine Index CRA

73%

New Preventive Medicine Index

One of the major reasons behind Pfizer's (PFE) interest in acquiring Wyeth (WYE) is the latter's focus on products outside of traditional pharmaceuticals – with 60% of Wyeth's revenue from last year derived from biological therapeutics and vaccines. It remains to be seen what happens to Wyeth's proposed deal to acquire Dutch vaccine maker Crucell (CRXL); however since it is much smaller (around $1B) and focuses on the development of vaccines, Pfizer would likely be interested in both companies together.

<> With the focus on preven...

Continue reading »

By Mike Havrilla (+1.04% risk: moderate) 01/25/09

2 comments

Applera Corp. Celera Group CRA <> ...

Continue reading »

62%

Analysts' Recommendation:	Buy
30 Days Ago:	Buy

Analysts' Target:	$38

<> <>

Analysts' Targets

Roth Capital Partners

$52

By Marian Filo (-24.55% risk: aggressive) 07/13/08

13 comments

Applera Corp. Celera Group CRA

62%

Celera Group, a molecular diagnostics business, engages in the identification and validation of diagnostic markers using proprietary genomics and proteomics discovery platforms. The company, through its strategic alliance with Abbott Laboratories, discovers, develops, and commercializes in vitro diagnostic products for disease detection, prediction of disease predisposition, disease progression monitoring, and therapy selection. It manufactures five product groups, including ViroSeq HIV-1 Genotyping System, an aid to physicians in monitoring and treating HIV-1 infection; products that are u...

Continue reading »

By Marian Filo (-24.55% risk: aggressive) 07/02/08

2 comments

... View All >

People Bullish on CRA

Marian Filo

Principal

62%

over 2 years ago

Mike Havrilla

Principal

73%

over 3 years ago

patel.nitesh@gmail.com

Analyst

5 %

over 3 years ago

oferf212

Analyst

81%

over 4 years ago

mbroudo

Associate

21%

over 4 years ago

People Bearish on CRA

... View All >

ROCK-STAR INVESTORS

Rank	Name	Sharpe Ratio	Avg Return	Followers
1	noshoes	21.10	+34.36%	531
2	Gerald Greene	18.14	+36.28%	286
3	stockmarketfunding.com	17.66	+23.07%	83
4	akiralegrand	13.47	+13.37%	69
5	anup2104	12.13	+132.16%	102

... more »

POPULAR STOCKS

Symbol	Company Name	Sentiment
C	Citigroup Inc
MO	Altria Group Inc
CAT	Caterpillar Inc
KO	The CocaCola Company
LEH	Lehman Brothers Holdings Inc
GS	Goldman Sachs Group Inc The

... more »

TODAY'S HEADLINES

LDK Solar's Growth Potential Offset by Gross Margin Pressure
by Paul Cheung (Zacks.com) about LDK

Cisco Systems Still a Wait and See
by Thomas Catino (Ant & Sons) about CSCO

The Merrill Lynch Diet: Starving Shareholders
by Zack Miller (BloggingStocks) about MER

Google Blows Q2: Multiple Compression to Continue
by Henry Blodget about GOOG

Stop Waiting for the Crash; Use a Regular Investment Plan
by Dan Caplinger (Fool.com) about SPY DJI

... more »

TODAY'S TOP PICKS

USO		Bullish on USO ... by jrmarketing2008
BWLD		Bullish on BWLD ... by jrmarketing2010
DO		Bullish on DO ... by jrmarketing2011
L		Bullish on L ... by jrmarketing2012
CMCSA		Bullish on CMCSA ... by jrmarketing2010

... more »

StreetInsider.com on CRA

Focus Relevant Interest Over 50% in Crescent

Crescent Directors Accept the Focus Offer

Focus and Crescent Release Their Bidder's and Target's Statements

Retransmission: Recommended Takeover of Crescent Gold by Focus Minerals

Recommended Takeover of Crescent Gold by Focus Minerals

Discussion Wall

+ Add

Be the first to start a discussion and earn 2 points.

... more »

More Resources

About Applera Corp. Celera Group - Answers.com

Historical Prices - Yahoo

Message Boards - BoardCentral.com

More Info: Yahoo | Google | Reuters

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.